Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
15.20
-0.05 (-0.33%)
Aug 15, 2025, 10:44 AM - Market open
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $42.34 million as of August 15, 2025. Its market cap has increased by 238.53% in one year.
Market Cap
42.34M
Enterprise Value
26.76M
1-Year Change
238.53%
Ranking
Category
Stock Price
$15.20
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $245.32M to $42.34M, a decrease of -82.74%. That is a compound annual growth rate of -20.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 42.48M | 63.96% |
| Dec 31, 2024 | 25.91M | -15.83% |
| Dec 29, 2023 | 30.78M | -70.81% |
| Dec 30, 2022 | 105.47M | -38.35% |
| Dec 31, 2021 | 171.08M | -24.02% |
| Dec 31, 2020 | 225.18M | -35.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |